Cite
HARVARD Citation
Nishimura, S. et al. (n.d.). Use of single-dose perioperative antimicrobial therapy is acceptable in recipients of living-donor renal transplants in the rituximab era. Journal of infection and chemotherapy. 25 (4), pp. 247-252. [Online].